vabomere
Generic: meropenem and vaborbactam
vabomere: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) | Phase 2 |
Clinical Trials (1)
An Open Label, Dose-finding, Pharmacokinetics, Safety, and Tolerability Study of a Single Dose Infusion of VABOMERE (Meropenem-Vaborbactam) in Pediatric Subjects From Birth to Less Than 18 Years of Age With Serious Bacterial Infections
Frequently asked questions
Who is developing vabomere?
vabomere is being developed by MELINTA THERAPEUTICS, INC. /NEW/.
How many clinical trials involve vabomere?
BioSniper tracks 1 clinical trial involving vabomere.
Get deeper analysis on vabomere
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis